Regeneron Pharmaceuticals (REGN) revealed a profit for its second quarter that advanced from the same period last year.
The company's earnings totaled $3.10 billion, or $27.97 per share. This compares with $0.90 billion, or $7.61 per share, in last year's second quarter.
Excluding items, Regeneron Pharmaceuticals reported adjusted earnings of $2.90 billion or $25.80 per share for the period.
Analysts had expected the company to earn $17.69 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.
The company's revenue for the quarter rose 163.6% to $5.14 billion from $1.95 billion last year.
Regeneron Pharmaceuticals earnings at a glance:
-Earnings (Q2): $2.90 Bln. vs. $0.85 Bln. last year.
-EPS (Q2): $25.80 vs. $7.16 last year.
-Analysts Estimate: $17.69
-Revenue (Q2): $5.14 Bln vs. $1.95 Bln last year.
For comments and feedback: editorial@rttnews.com